Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver

被引:60
|
作者
Wulf, J [1 ]
Hädinger, U [1 ]
Oppitz, U [1 ]
Thiele, W [1 ]
Flentje, M [1 ]
机构
[1] Univ Wurzburg, Dept Radiotherapy, D-97080 Wurzburg, Germany
关键词
stereotactic radiotherapy; stereotactic body frame; conformal radiotherapy; computed tomography simulation; treatment accuracy; dose-volume histogram;
D O I
10.1016/S0167-8140(02)00372-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Previous analyses of target reproducibility in extracranial stereotactic radiotherapy have revealed standard security margins for planning target volume (PTV) definition of 5 mm in axial and 5-10 mm in longitudinal direction. In this study the reproducibility of the clinical target volume (CTV) of lung and liver tumors within the PTV over the complete course of hypofractionated treatment is evaluated. The impact of target mobility on dose to the CTV is assessed by dose-volume histograms (DVH). Materials and methods: Twenty-two pulmonary and 21 hepatic targets were treated with three stercotactic fractions of 10 Gy to the PTV-enclosing 100%-isodose with normalization to 150% at the isocenter. A conformal dose distribution was related to the PTV, which was defined by margins of 5-10 mm added to the CTV. Prior to each fraction a computed tomography (CT)-simulation over the complete target volume was performed resulting in a total of 60 CT-simulations for lung and 58 CT-simulations for hepatic targets. The CTV from each CT-simulation was segmented and matched with the CT-study used for treatment planning. A DVH of the simulated CTV was calculated for each fraction. The target coverage (TC) of dose to the simulated CTV was defined as the proportion of the CTV receiving at least the reference dose (100%). Results: A decrease of TC to <95% was found in 3/60 simulations (5%) of pulmonary and 7/58 simulations (12%) of hepatic targets. In two of 22 pulmonary targets (9%) and in four of 21 hepatic targets (19%) a TC of <95% occurred in at least one fraction. At risk for a 3 decreased TC <95% were pulmonary targets with increased breathing mobility and hepatic targets with a CTV exceeding 100 cm(3). Conclusions: Target reproducibility was precise within the reference isodose in 91% of lung and 81% of liver tumors with a TC of the complete CTV greater than or equal to95% at each fraction of treatment. Pulmonary targets with increased breathing mobility and liver tumors >100 cm(3) are at risk for target deviation exceeding the standard security margins for PTV-definition at least for one fraction and require individual evaluation of sufficient margins. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [31] Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets
    Haedinger, U
    Krieger, T
    Flentje, M
    Wulf, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (01): : 239 - 249
  • [32] Evaluation of target coverage in lung stereotactic radiotherapy with Cyberknife system
    Ricotti, R.
    Seregni, M.
    Ciardo, D.
    Vigorito, S.
    Rondi, E.
    Piperno, G.
    Zerella, M. A.
    Arculeo, S.
    Francia, C.
    Sibio, D.
    Cattani, F.
    Orecchia, R.
    Riboldi, M.
    Baroni, G.
    Jereczek-Fossa, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1107 - S1108
  • [33] Tumor Size and Dose Impact Recurrence after Stereotactic Body Radiotherapy (SBRT) for Liver Metastases (LM) from Colorectal Cancer (CRC)
    Pirlamarla, A. K.
    Ruth, K.
    Yankey, H. N.
    Dougherty, T.
    Rosser, C.
    Hayes, S. B.
    Price, R. A., Jr.
    Meyer, J. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E148 - E148
  • [34] Impact of lung tumor motion on dose delivered to organ at risk in lung stereotactic body radiation therapy
    Savanovic, Milovan
    Strbac, Bojan
    Jaros, Drazan
    Cazic, Dejan
    Foulquier, Jean Noel
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2020, 9 (3-4) : 191 - 198
  • [35] Clinical Outcomes of Single Dose Stereotactic Radiotherapy for Lung Metastases
    Osti, Mattia F.
    Carnevale, Alessia
    Valeriani, Maurizio
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Cortesi, Enrico
    Martelli, Massimo
    Enrici, Riccardo Maurizi
    [J]. CLINICAL LUNG CANCER, 2013, 14 (06) : 699 - 703
  • [36] Volume Dose Prescription in Stereotactic Body Radiotherapy for Lung Cancer
    Terahara, A.
    Saotome, N.
    Miyamoto, K.
    Omori, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S207 - S207
  • [37] Influence of respiration on dose calculation in stereotactic body radiotherapy of the lung
    Yamazaki R.
    Onimaru R.
    Katoh N.
    Inoue T.
    Nishioka T.
    Shirato H.
    Date H.
    [J]. Radiological Physics and Technology, 2014, 7 (2) : 284 - 289
  • [38] Dosimetric Impact of Image-Guided Radiotherapy in Liver Stereotactic Radiotherapy
    Eccles, Cynthia L.
    Lindsay, Patricia E.
    Craig, Tim D.
    Kim, John J.
    Dawson, Laura A.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2013, 44 (01) : 5 - 13
  • [39] Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer
    Matsugi K.
    Nakamura M.
    Miyabe Y.
    Yamauchi C.
    Matsuo Y.
    Mizowaki T.
    Hiraoka M.
    [J]. Radiological Physics and Technology, 2013, 6 (1) : 233 - 240
  • [40] Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity
    Meijneke, Thomas R.
    Petit, Steven F.
    Wentzler, Davy
    Hoogeman, Mischa
    Nuyttens, Joost J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 423 - 427